Filters close
Released: 30-Dec-2019 4:35 PM EST
Turmeric and the Anti-Cancer Properties of Curcumin Discussed in Research Review
Sbarro Health Research Organization (SHRO)

The review has collected studies concerning the anticancer potential of curcumin against the most widespread cancers and also describing the molecular mechanisms of action.

Released: 24-Dec-2019 10:20 AM EST
Researchers Probe Emerging Mesothelioma Treatment Targeting PP2A and CDK
Sbarro Health Research Organization (SHRO)

A collaborative study of researchers from Thomas Jefferson University, Sbarro Institute for Cancer Research and Molecular Medicine of Temple University, University of Siena, and from the Spanish Center for the Applied Medical Research (CIMA) of the University of Navarra have discovered a novel targetable axis in mesothelioma patients.

5-Dec-2019 10:55 AM EST
Land of Fires: Evaluation of heavy metal blood-levels in populations exposed to toxic waste in southern Italy
Sbarro Health Research Organization (SHRO)

Toxic environmental agents, to which anyone is involuntarily exposed, represent non-negligible risk for human health and, therefore, environmental contamination has become a theme of primary importance worldwide.

Released: 31-Oct-2019 8:55 AM EDT
Medicine, Media & Patients: A New Professional Language
Sbarro Health Research Organization (SHRO)

Panel to Convene at Annual Medical conference at NIAF

   
Released: 21-Oct-2019 10:00 AM EDT
SHRO Founder Presented with Career Award and Appointed Chair of Italian Cancer Association FONICAP
Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization founder and Director, Antonio Giordano, M.D., Ph.D., has been recognized with a career award "for the great contributions he has made and which he will continue to make to science, medicine and research.

Released: 2-Oct-2019 2:05 PM EDT
Treatment for Incurable Breast Cancer, Melanoma Improved by Adding Local Anesthetics
Sbarro Health Research Organization (SHRO)

Results suggest that the combined treatment can lower the effective chemotherapy dosage, reduce side effects, improve tumor cell apoptosis, and reduce tumor cell migration.

Released: 12-Aug-2019 10:45 AM EDT
Untreatable Olive Tree Disease Can Be Contained, But Must Be Better Monitored, says SHRO Researcher
Sbarro Health Research Organization (SHRO)

Xylella fastidiosa, subsp. pauca is a bacterial pathogen currently devastating the olive orchards in Southern Italy (Apulia). Due to the epidemic, local production of olive oil has dropped by 90%, olive mills are shut down, the regional economy is suffering, and an invaluable cultural asset is compromised.

   
Released: 14-Jun-2019 11:05 AM EDT
New Natural Therapeutic Agent to Fight Diabetic Nephropathy
Sbarro Health Research Organization (SHRO)

The extract successfully restored the blood glucose levels, body weight, and normalized oxidative stress on renal function in a test group of Zucker diabetic fatty rats.

Released: 11-Jun-2019 4:10 PM EDT
Exploiting RB1 Predictive Value for Cancer Therapy in the Clinical Setting: Lost in Translation
Sbarro Health Research Organization (SHRO)

RB1 status has emerged not only as a key factor in cancer development and progression, but also as a crucial determinant of cell fate in response to various anticancer treatments

Released: 4-Jun-2019 9:55 AM EDT
Cervical Cancer During Pregnancy, Though Serious, is Highly Treatable According to New Research Review
Sbarro Health Research Organization (SHRO)

“Individualized therapies are strongly recommended and the treatment decision should be made collaboratively with a multidisciplinary team consisting of obstetricians, gynecologists, oncologists, pediatricians, and psychologists,” says researcher.

Released: 20-May-2019 4:05 AM EDT
Brain Cancer Drug Reactivates Body's Natural Defenses
Sbarro Health Research Organization (SHRO)

Drug reactivates p53 tumor suppressor protein and increases chemotherapy effectiveness in potential glioblastoma breakthrough.

Released: 10-Apr-2019 12:05 PM EDT
Enzyme Inhibition May Lead to New Melanoma Therapy, Say Researchers at Fox Chase with Support from Sbarro Institute
Sbarro Health Research Organization (SHRO)

Inhibition of the cellular enzyme thymine DNA glycosylase (TDG) may be an effective treatment for melanoma, according to research published in the journal Oncogene in January. The paper, “Thymine DNA glycosylase as a novel target for melanoma,” describes how inhibition of TDG, known for its role in cell repair and proliferation, may be used to trigger cell death of cancerous melanoma cells and halt tumor growth.

Released: 14-Mar-2019 9:00 AM EDT
Decoy Damaged DNA Discovers New Gene Repair Protein
Sbarro Health Research Organization (SHRO)

A synthetic DNA structure was used as bait to capture nuclear proteins, revealing previously unknown role of HNRNPD in the cellular response to DNA damage.

Released: 4-Feb-2019 11:45 AM EST
Potential to Better Treat Mesothelioma Revealed by Precision Medicine Research
Sbarro Health Research Organization (SHRO)

Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist.

Released: 11-Dec-2018 7:55 AM EST
Metastatic Breast Cancer Survival Improves with New CDK-Inhibitor Plus Endocrine Therapy
Sbarro Health Research Organization (SHRO)

A study finds that palbociclib, in combination with endocrine therapy, improves progression free survival

Released: 10-Dec-2018 2:05 PM EST
SHRO Partners with Film Festival to Recognize Importance of Virtual Reality in Medicine and Celebrate Italian-Origin Filmmakers
Sbarro Health Research Organization (SHRO)

This week, SHRO partners with the Italian Movie Award International Film Festival to support Italian-American work in cinema, particularly in recognition for accomplishments with the use of Virtual Reality (VR) in applications in medicine

   


close
0.76142